APA (7th ed.) Citation

L, Z., J, L., Y, L., Z, H., X, Y., JL, L., . . . J, Z. (2025). LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan Area. Advances in therapy, 42(6), 2874. https://doi.org/10.1007/s12325-025-03199-3

Chicago Style (17th ed.) Citation

L, Zhao, et al. "LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan Area." Advances in Therapy 42, no. 6 (2025): 2874. https://doi.org/10.1007/s12325-025-03199-3.

MLA (9th ed.) Citation

L, Zhao, et al. "LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan Area." Advances in Therapy, vol. 42, no. 6, 2025, p. 2874, https://doi.org/10.1007/s12325-025-03199-3.